Parallel Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,990
Closed -$974K 3456
2024
Q1
$974K Buy
2,990
+1,722
+136% +$423K 0.03% 371
2023
Q4
$242K Buy
1,268
+47
+4% +$8.88K 0.01% 712
2023
Q3
$243K Buy
1,221
+295
+32% +$69.8K 0.01% 706
2023
Q2
$264K Buy
926
+9
+1% +$2.5K 0.01% 664
2023
Q1
$199K Sell
917
-27
-3% -$5.26K 0.01% 773
2022
Q4
$194K Sell
944
-17
-2% -$4.3K 0.01% 710
2022
Q3
$267K Buy
961
+23
+2% +$5.85K 0.01% 577
2022
Q2
$179K Buy
938
+58
+7% +$10.2K 0.01% 729
2022
Q1
$171K Sell
880
-7
-0.8% -$1.15K 0.01% 788
2021
Q4
$158K Sell
887
-15
-2% -$2.96K 0.01% 837
2021
Q3
$186K Sell
902
-486
-35% -$95.4K 0.01% 750
2021
Q2
$263K Buy
1,388
+22
+2% +$3.6K 0.01% 579
2021
Q1
$178K Hold
1,366
0.01% 674
2020
Q4
$142K Sell
1,366
-2
-0.1% -$173 0.01% 699
2020
Q3
$104K Buy
1,368
+5
+0.4% +$284 0.01% 771
2020
Q2
$64K Buy
1,363
+663
+95% +$27.3K ﹤0.01% 949
2020
Q1
$23K Buy
700
+695
+13,900% +$27.6K ﹤0.01% 1260
2019
Q4
$0 Hold
5
﹤0.01% 2523
2019
Q3
$0 Hold
5
﹤0.01% 2523
2019
Q2
$0 Buy
+5
New +$243 ﹤0.01% 2467

Other funds holding SWAV

Parallel Advisors's SWAV Position: Q2 2024 in Review

Parallel Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 2,990 shares — an estimated $974K sold.

Parallel Advisors first reported a position in SWAV in Q2 2019 and held it in 20 quarters. The position peaked at $974K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Parallel Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Parallel Advisors sold 2,990 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $974K.
  • Parallel Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2019 and held it in 20 quarters.
  • Parallel Advisors's Shockwave Medical, Inc. Common Stock position peaked at $974K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.